History | Parkinson’s disease in adults | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Guidance published

Committee member list (PDF 407 KB)

Published:

19 July 2017
Equality impact assessment 4 (PDF 217 KB)

Published:

19 July 2017
Consultation comments and responses (PDF 5.12 MB)

Published:

05 January 2018

Equality and health inequalities assessment

Equality impact assessment 3 (PDF 138 KB)

Published:

13 December 2016
Equality impact assessment 4 (PDF 217 KB)

Published:

20 March 2017

Stakeholder list updated

Stakeholder list (PDF 47 KB)

Published:

16 February 2017

Draft guidance consultation

Draft guidance consultation
Guideline appendix A - Committee and DOI (PDF 327 KB)

Published:

04 October 2016
Guideline appendix B - Guideline scope (PDF 197 KB)

Published:

04 October 2016
Guideline appendix C - Review protocols (PDF 486 KB)

Published:

04 October 2016
Guideline appendix D - Information needs of people with Parkinson's disease and their families and carers (PDF 5.06 MB)

Published:

04 October 2016
Guideline appendix E - GRADE profiles (PDF 6.3 MB)

Published:

04 October 2016
Guideline appendix F - Full health economics report (PDF 1.95 MB)

Published:

04 October 2016
Guideline appendix G - Excluded studies (PDF 858 KB)

Published:

04 October 2016
Guideline appendix H - Deleted text from NICE clinical guideline 35 (CG35) (PDF 4.71 MB)

Published:

04 October 2016
Guideline appendix I - Search strategies (PDF 456 KB)

Published:

04 October 2016
Guideline appendix J - Old guideline references (PDF 160 KB)

Published:

04 October 2016
Guideline appendix K - Parkinson's disease society communication table (PDF 253 KB)

Published:

04 October 2016
Guideline appendix L - Economic modelling for Parkinson's disease nurse specialist care (PDF 268 KB)

Published:

04 October 2016
Comments form (MSWord 61 KB)

Published:

04 October 2016
Stakeholder list (PDF 46 KB)

Published:

04 October 2016
Equality impact assessment (PDF 273 KB)

Published:

04 October 2016
Draft guideline (PDF 2.64 MB)

Published:

04 October 2016
Short version of draft guideline (PDF 550 KB)

Published:

04 October 2016
Guideline appendix M - Call for evidence (PDF 233 KB)

Published:

04 October 2016
Guideline appendix N - Research recommendations (PDF 228 KB)

Published:

04 October 2016

Pre-consultation documents released

Economic plan (PDF 74 KB)

Published:

24 August 2016
Review questions (PDF 70 KB)

Published:

24 August 2016
Search strategies (PDF 458 KB)

Published:

24 August 2016

Committee meetings

Committee meeting
Minutes 1 (PDF 161 KB)

Published:

19 November 2014
Minutes 2 (PDF 200 KB)

Published:

08 January 2015
Minutes 3 (PDF 200 KB)

Published:

19 February 2015
Minutes 4 (PDF 156 KB)

Published:

27 April 2015
Minutes 5 (PDF 275 KB)

Published:

08 June 2015
Minutes 6 (PDF 234 KB)

Published:

20 July 2015
Minutes 7 (PDF 246 KB)

Published:

11 September 2015
Minutes 8 (PDF 242 KB)

Published:

19 October 2015
Minutes 9 (PDF 242 KB)

Published:

21 December 2015
Minutes 10 (PDF 252 KB)

Published:

10 March 2016
Minutes 11 (PDF 239 KB)

Published:

18 April 2016
Minutes 12 (PDF 235 KB)

Published:

09 June 2016
Minutes 13 (PDF 298 KB)

Published:

14 July 2016
Minutes 14 (PDF 294 KB)

Published:

28 November 2016

Call for evidence

Call for evidence information
Call for evidence (PDF 182 KB)

Published:

22 June 2015

Final scope

Final scope (PDF 195 KB)

Published:

01 December 2014

Guideline development group membership

Guideline development group membership (PDF 123 KB)

Published:

19 November 2014

Equality impact assessment form

Equality impact assessment form (PDF 224 KB)

Published:

19 November 2014

Scope consultation comments table

Scope consultation comments table (PDF 1018 KB)

Published:

19 November 2014

Scope consultation

Scope consultation information
Draft scope for consultation (PDF 192 KB)

Published:

04 August 2014
Stakeholder workshop notes (PDF 242 KB)

Published:

18 August 2014
Stakeholder list (PDF 119 KB)

Published:

21 April 2015